Skip to main content
. 2013 Apr;41(4):744–753. doi: 10.1124/dmd.112.050294

TABLE 4.

Empirical scaling factors used for prediction of Kp values and in vitro hepatic and renal CLint data determined by optimization of the PBPK model using simultaneous fitting of in vivo concentration-time data from intact and anhepatic patients

Parameter Initial Parameter Estimate Model Fitted Parameter Estimatea Model Fitted Scalara CV% for Fitted Scalara
Kpb 0.54 9.5
Renal CLint,UGT (l/h per gram tissue) 0.786c 13.6 17.3 39
Hepatic CLint (l/h per gram tissue)d 1.57c 14.5 9.21 59

CV, coefficient of variation.

a

Parameters estimated by simultaneous fitting of in vivo concentration-time data from intact and anhepatic patients, as detailed in the Materials and Methods.

b

Initial Kp values estimated using the Rodgers and Rowland (2006) method.

c

Initial CLint data taken from microsomal substrate depletion assays in the presence of BSA. Full details are presented in Table 2.

d

Combined CLint,P450 and CLint,UGT data.